Association between the ERCC2 Asp312Asn polymorphism and risk of cancer

Oncotarget

Volumn 8, Issue 29, 2017, Pages 48488-48506

  Xiao, Feifan ^a   Pu, Jian ^b   Wen, Qiongxian ^c   Huang, Qin ^d   Zhang, Qinle ^e   Huang, Birong ^a   Huang, Shanshan ^a   Lan, Aihua ^a   Zhang, Yuening ^a   Li, Jiatong ^a   Zhao, Dong ^a   Shen, Jing ^a   Wu, Huayu ^a   He, Yan ^f   Li, Hongtao ^a   Yang, Xiaoli ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

^b YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

^c GUILIN MEDICAL UNIVERSITY   (China)

^d GUANGXI UNIVERSITY FOR NATIONALITIES   (China)

^e Guangxi Matemal and Child Health Hospital   (China)

^f FIRST AFFILIATED HOSPITAL OF GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Cancer; ERCC2 Asp312Asn; Meta analysis; Polymorphism; Trial sequence analysis

Indexed keywords

ASPARAGINE; ASPARTIC ACID; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

ASIAN; BLADDER CANCER; BREAST CANCER; CANCER RISK; CARCINOGENESIS; CAUCASIAN; ERCC2 GENE; ESOPHAGUS CANCER; ETHNICITY; GENETIC ASSOCIATION; GENOTYPE; HEAD AND NECK CANCER; HUMAN; LUNG CANCER; MALIGNANT NEOPLASM; NONHODGKIN LYMPHOMA; PROSTATE CANCER; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER; STOMACH CANCER; SYSTEMATIC REVIEW; ALLELE; AMINO ACID SUBSTITUTION; ANIMAL; CASE CONTROL STUDY; GENETIC ASSOCIATION STUDY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; ODDS RATIO; PUBLISHING; RISK;

ALLELES; AMINO ACID SUBSTITUTION; ANIMALS; CASE-CONTROL STUDIES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK; XERODERMA PIGMENTOSUM GROUP D PROTEIN;

EID: 85024388463     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.17290     Document Type: Review

References (127)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-74. doi: 10.1016/j.cell.2011.02.013
2. Castro J, Ribo M, Benito A, Vilanova M. Mini-review: nucleus-targeted ribonucleases as antitumor drugs. Curr Med Chem. 2013; 20: 1225-31
3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5-29. doi: 10.3322/caac.21254
4. Huang X, Gao Y, He J, Cai J, Ta N, Jiang H, Zhu J, Zheng J. The association between RFC1 G80A polymorphism and cancer susceptibility: Evidence from 33 studies. J Cancer. 2016; 7: 144-52. doi: 10.7150/jca.13303
5. Qixing M, Gaochao D, Wenjie X, Rong Y, Feng J, Lin X, Mantang Q, Qiang C. Predictive Value of Ercc1 and Xpd Polymorphisms for Clinical Outcomes of Patients Receiving Neoadjuvant Therapy: A Prisma-Compliant Meta-Analysis. Medicine (Baltimore). 2015; 94: e1593. doi: 10.1097/md.0000000000001593
6. Benhamou S, Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am J Epidemiol. 2005; 161: 1-14. doi: 10.1093/aje/kwi018
7. Alanazi M, Pathan AA, Ajaj SA, Khan W, Shaik JP, Al Tassan N, Parine NR. DNA Repair Genes XRCC1, XRCC3, XPD, and OGG1 Polymorphisms among the Central Region Population of Saudi Arabia. Biol Res. 2013; 46: 161-7. doi: 10.4067/s0716-97602013000200007
8. Ouyang FD, Yang FL, Chen HC, Khan MA, Huang FM, Wan XX, Xu AH, Huang X, Zhou MJ, Fang Q, Zhang DZ. Polymorphisms of DNA repair genes XPD, XRCC1, and OGG1, and lung adenocarcinoma susceptibility in Chinese population. Tumour Biol. 2013; 34: 2843-8. doi: 10.1007/s13277-013-0844-6
9. Clarkson SG, Wood RD. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst). 2005; 4: 1068-74. doi: 10.1016/j.dnarep.2005.07.001
10. Lunn RM, Helzlsouer KJ, Parshad R, Umbach DM, Harris EL, Sanford KK, Bell DA. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis. 2000; 21: 551-5
11. Hu YY, Yuan H, Jiang GB, Chen N, Wen L, Leng WD, Zeng XT, Niu YM. Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: a metaanalysis based on 7,122 subjects. PLoS One. 2012; 7: e35220. doi: 10.1371/journal.pone.0035220
12. Feng Z, Ni Y, Dong W, Shen H, Du J. Association of ERCC2/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: a systemic review and meta-analysis. Mol Biol Rep. 2012; 39: 57-69. doi: 10.1007/s11033-011-0710-9
13. Geng P, Ou J, Li J, Liao Y, Wang N, Xie G, Sa R, Liu C, Xiang L, Liang H. A Comprehensive Analysis of Influence ERCC Polymorphisms Confer on the Development of Brain Tumors. Mol Neurobiol. 2015; 53:2705-14. doi: 10.1007/s12035-015-9371-3
14. Wen F, Zhao Z, Liu C, Yin Q, Weng J, Wang Y, Ma Y. A pooled analysis of the ERCC2 Asp312Asn polymorphism and esophageal cancer susceptibility. Tumour Biol. 2014; 35: 2959-65. doi: 10.1007/s13277-013-1380-0
15. Zhu ML, He J, Wang M, Sun MH, Jin L, Wang X, Yang YJ, Wang JC, Zheng L, Xiang JQ, Wei QY. Potentially functional polymorphisms in the ERCC2 gene and risk of esophageal squamous cell carcinoma in Chinese populations. Sci Rep. 2014; 4: 6281. doi: 10.1038/srep06281
16. Yang R, Zhang C, Malik A, Shen ZD, Hu J, Wu YH. Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies. World J Gastroenterol. 2014; 20: 16765-73. doi: 10.3748/wjg.v20.i44.16765
17. Li C, Jiang Z, Liu X. XPD Lys (751) Gln and Asp (312) Asn polymorphisms and bladder cancer risk: a metaanalysis. Mol Biol Rep. 2010; 37: 301-9. doi: 10.1007/s11033-009-9693-1
18. Wu Y, Yang Y. Complex association between ERCC2 gene polymorphisms, gender, smoking and the susceptibility to bladder cancer: a meta-analysis. Tumour Biol. 2014; 35: 5245-57. doi: 10.1007/s13277-014-1682-x
19. Li SX, Dai QS, Chen SX, Zhang SD, Liao XY, Deng X, Chi HB, Li FJ, Zhu JH, Jiang YY. Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis. Tumour Biol. 2014; 35: 3905-15. doi: 10.1007/s13277-013-1519-z
20. Jiang Z, Li C, Xu Y, Cai S, Wang X. Associations between XPD polymorphisms and risk of breast cancer: a metaanalysis. Breast Cancer Res Treat. 2010; 123: 203-12. doi: 10.1007/s10549-010-0751-0
21. Yan Y, Liang H, Light M, Li T, Deng Y, Li M, Li S, Qin X. XPD Asp312Asn and Lys751Gln polymorphisms and breast cancer susceptibility: a meta-analysis. Tumour Biol. 2014; 35: 1907-15. doi: 10.1007/s13277-013-1256-3
22. Yao L, Qiu LX, Yu L, Yang Z, Yu XJ, Zhong Y, Hu XC, Yu L. The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: a meta-analysis involving 22,766 subjects. Breast Cancer Res Treat. 2010; 123: 227-31. doi: 10.1007/s10549-010-0754-x
23. Gómez-Díaz B, DE LA Luz Ayala-Madrigal M, Gutiérrez-Angulo M, Valle-Solis AE, Linares-González LM, González-Guzmán R, Cruz-Guillén D, Cedeño-Garcidueñas AL, Canto P, López-Hernández LB. Analysis of ERCC1 and ERCC2 gene variants in osteosarcoma, colorectal and breast cancer. Oncol Lett. 2015; 9: 1657-61. doi: 10.3892/ol.2015.2894
24. Wu JS, Chen YP, Wang LC, Yang YJ, Deng CW, Hou BX, He ZL, Chen JX. Implication of polymorphisms in DNA repair genes with an increased risk of hepatocellular carcinoma. Genet Mol Res. 2014; 13: 3812-8. doi: 10.4238/2014.May.16.5
25. Mahimkar MB, Samant TA, Kannan S, Patil T. Influence of genetic polymorphisms on frequency of micronucleated buccal epithelial cells in leukoplakia patients. Oral Oncol. 2010; 46: 761-6. doi: 10.1016/j.oraloncology.2010.08.009
26. Wang Y, Spitz MR, Lee JJ, Huang M, Lippman SM, Wu X. Nucleotide excision repair pathway genes and oral premalignant lesions. Clin Cancer Res. 2007; 13: 3753-8. doi: 10.1158/1078-0432.ccr-06-1911
27. Majumder M, Sikdar N, Ghosh S, Roy B. Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators. Int J Cancer. 2007; 120: 2148-56. doi: 10.1002/ijc.22547
28. Han J, Colditz GA, Liu JS, Hunter DJ. Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1539-44. doi: 10.1158/1055-9965.epi-04-0846
29. Lovatt T, Alldersea J, Lear JT, Hoban PR, Ramachandran S, Fryer AA, Smith AG, Strange RC. Polymorphism in the nuclear excision repair gene ERCC2/XPD: association between an exon 6-exon 10 haplotype and susceptibility to cutaneous basal cell carcinoma. Hum Mutat. 2005; 25: 353-9. doi: 10.1002/humu.20158
30. Li C, Hu Z, Liu Z, Wang LE, Strom SS, Gershenwald JE, Lee JE, Ross MI, Mansfield PF, Cormier JN, Prieto VG, Duvic M, Grimm EA, et al. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol Biomarkers Prev. 2006; 15: 2526-32. doi: 10.1158/1055-9965.epi-06-0672
31. Millikan RC, Hummer A, Begg C, Player J, de Cotret AR, Winkel S, Mohrenweiser H, Thomas N, Armstrong B, Kricker A, Marrett LD, Gruber SB, Culver HA, et al. Polymorphisms in nucleotide excision repair genes and risk of multiple primary melanoma: the Genes Environment and Melanoma Study. Carcinogenesis. 2006; 27: 610-8. doi: 10.1093/carcin/bgi252
32. Debniak T, Scott RJ, Huzarski T, Byrski T, Masojc B, van de Wetering T, Serrano-Fernandez P, Gorski B, Cybulski C, Gronwald J, Debniak B, Maleszka R, Kladny J, et al. XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res Treat. 2006; 98: 209-15. doi: 10.1007/s10549-005-9151-2
33. Moreno V, Gemignani F, Landi S, Gioia-Patricola L, Chabrier A, Blanco I, Gonzalez S, Guino E, Capella G, Canzian F. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin Cancer Res. 2006; 12: 2101-8. doi: 10.1158/1078-0432. ccr-05-1363
34. Hansen RD, Sorensen M, Tjonneland A, Overvad K, Wallin H, Raaschou-Nielsen O, Vogel U. XPA A23G, XPC Lys939Gln, XPD Lys751Gln and XPD Asp312Asn polymorphisms, interactions with smoking, alcohol and dietary factors, and risk of colorectal cancer. Mutat Res. 2007; 619: 68-80. doi: 10.1016/j.mrfmmm.2007.02.002
35. Joshi AD, Corral R, Siegmund KD, Haile RW, Le Marchand L, Martinez ME, Ahnen DJ, Sandler RS, Lance P, Stern MC. Red meat and poultry intake, polymorphisms in the nucleotide excision repair and mismatch repair pathways and colorectal cancer risk. Carcinogenesis. 2009; 30: 472-9. doi: 10.1093/carcin/bgn260
36. Ni M, Zhang WZ, Qiu JR, Liu F, Li M, Zhang YJ, Liu Q, Bai J. Association of ERCC1 and ERCC2 polymorphisms with colorectal cancer risk in a Chinese population. Sci Rep. 2014; 4: 4112. doi: 10.1038/srep04112
37. An J, Liu Z, Hu Z, Li G, Wang LE, Sturgis EM, El-Naggar AK, Spitz MR, Wei Q. Potentially functional single nucleotide polymorphisms in the core nucleotide excision repair genes and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol Biomarkers Prev. 2007; 16: 1633-8. doi: 10.1158/1055-9965.epi-07-0252
38. Harth V, Schafer M, Abel J, Maintz L, Neuhaus T, Besuden M, Primke R, Wilkesmann A, Thier R, Vetter H, Ko YD, Bruning T, Bolt HM, et al. Head and neck squamous-cell cancer and its association with polymorphic enzymes of xenobiotic metabolism and repair. J Toxicol Environ Health A. 2008; 71: 887-97. doi: 10.1080/15287390801988160
39. Abbasi R, Ramroth H, Becher H, Dietz A, Schmezer P, Popanda O. Laryngeal cancer risk associated with smoking and alcohol consumption is modified by genetic polymorphisms in ERCC5, ERCC6 and RAD23B but not by polymorphisms in five other nucleotide excision repair genes. Int J Cancer. 2009; 125: 1431-9. doi: 10.1002/ijc.24442
40. Ji YB, Tae K, Lee YS, Lee SH, Kim KR, Park CW, Park BL, Shin HD. XPD Polymorphisms and Risk of Squamous Cell Carcinoma of the Head and Neck in a Korean Sample. Clin Exp Otorhinolaryngol. 2010; 3: 42-7. doi: 10.3342/ceo.2010.3.1.42
41. Gugatschka M, Dehchamani D, Wascher TC, Friedrich G, Renner W. DNA repair gene ERCC2 polymorphisms and risk of squamous cell carcinoma of the head and neck. Exp Mol Pathol. 2011; 91: 331-4. doi: 10.1016/j.yexmp.2011.03.004
42. Das S, Bhowmik A, Bhattacharjee A, Choudhury B, Naiding M, Laskar AK, Ghosh SK, Choudhury Y. XPD, APE1, and MUTYH polymorphisms increase head and neck cancer risk: effect of gene-gene and gene-environment interactions. Tumour Biol. 2015; 36: 7569-79. doi: 10.1007/s13277-015-3472-5
43. Liu G, Zhou W, Yeap BY, Su L, Wain JC, Poneros JM, Nishioka NS, Lynch TJ, Christiani DC. XRCC1 and XPD polymorphisms and esophageal adenocarcinoma risk. Carcinogenesis. 2007; 28: 1254-8. doi: 10.1093/carcin/bgm020
44. Ye W, Kumar R, Bacova G, Lagergren J, Hemminki K, Nyren O. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a populationbased case-control study in Sweden. Carcinogenesis. 2006; 27: 1835-41. doi: 10.1093/carcin/bgl017
45. Tse D, Zhai R, Zhou W, Heist RS, Asomaning K, Su L, Lynch TJ, Wain JC, Christiani DC, Liu G. Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk. Cancer Causes Control. 2008; 19: 1077-83. doi: 10.1007/s10552-008-9171-4
46. Pan J, Lin J, Izzo JG, Liu Y, Xing J, Huang M, Ajani JA, Wu X. Genetic susceptibility to esophageal cancer: the role of the nucleotide excision repair pathway. Carcinogenesis. 2009; 30: 785-92. doi: 10.1093/carcin/bgp058
47. Huang CG, Liu T, Lv GD, Liu Q, Feng JG, Lu XM. Analysis of XPD genetic polymorphisms of esophageal squamous cell carcinoma in a population of Yili Prefecture, in Xinjiang, China. Mol Biol Rep. 2012; 39: 709-14. doi: 10.1007/s11033-011-0789-z
48. Yin QH, Liu C, Hu JB, Meng RR, Li L, Wang YJ. XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev. 2013; 14: 231-6
49. Smedby KE, Lindgren CM, Hjalgrim H, Humphreys K, Schollkopf C, Chang ET, Roos G, Ryder LP, Falk KI, Palmgren J, Kere J, Melbye M, Glimelius B, et al. Variation in DNA repair genes ERCC2, XRCC1, and XRCC3 and risk of follicular lymphoma. Cancer Epidemiol Biomarkers Prev. 2006; 15: 258-65. doi: 10.1158/1055-9965.epi-05-0583
50. Shen M, Zheng T, Lan Q, Zhang Y, Zahm SH, Wang SS, Holford TR, Leaderer B, Yeager M, Welch R, Kang D, Boyle P, Zhang B, et al. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum Genet. 2006; 119: 659-68. doi: 10.1007/s00439-006-0177-2
51. Song B, Zhu JY, Liu J, Wang ZH, Shi Y, Lü LY, Zheng Y. [Association of Gene Polymorphisms in the DNA Repair Gene XPD with Risk of Non-Hodgkin's Lymphoma]. [Article in Chinese]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2008; 16: 97-100
52. Baris S, Celkan T, Batar B, Guven M, Ozdil M, Ozkan A, Apak H, Yildiz I. Association between genetic polymorphism in DNA repair genes and risk of B-cell lymphoma. Pediatr Hematol Oncol. 2009; 26: 467-72. doi: 10.3109/08880010903096201
53. Worrillow L, Roman E, Adamson PJ, Kane E, Allan JM, Lightfoot TJ. Polymorphisms in the nucleotide excision repair gene ERCC2/XPD and risk of non-Hodgkin lymphoma. Cancer Epidemiol. 2009; 33: 257-60. doi: 10.1016/j.canep.2009.08.002
54. El-Din MA, Khorshied MM, El-Saadany ZA, El-Banna MA, Reda Khorshid OM. Excision repair cross-complementing group 2/Xeroderma pigmentousm complementation group D (ERCC2/XPD) genetic variations and susceptibility to diffuse large B cell lymphoma in Egypt. Int J Hematol. 2013; 98: 681-6. doi: 10.1007/s12185-013-1462-1
55. Agalliu I, Kwon EM, Salinas CA, Koopmeiners JS, Ostrander EA, Stanford JL. Genetic variation in DNA repair genes and prostate cancer risk: results from a populationbased study. Cancer Causes Control. 2010; 21: 289-300. doi: 10.1007/s10552-009-9461-5
56. Mirecka A, Paszkowska-Szczur K, Scott RJ, Gorski B, van de Wetering T, Wokolorczyk D, Gromowski T, Serrano-Fernandez P, Cybulski C, Kashyap A, Gupta S, Golab A, Slojewski M, et al. Common variants of xeroderma pigmentosum genes and prostate cancer risk. Gene. 2014; 546: 156-61. doi: 10.1016/j.gene.2014.06.026
57. Bau DT, Wu HC, Chiu CF, Lin CC, Hsu CM, Wang CL, Wang RF, Tsai FJ. Association of XPD polymorphisms with prostate cancer in Taiwanese patients. Anticancer Res. 2007; 27: 2893-6
58. Mandal RK, Gangwar R, Mandhani A, Mittal RD. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India. DNA Cell Biol. 2010; 29: 183-90. doi: 10.1089/dna.2009.0956
59. Lavender NA, Komolafe OO, Benford M, Brock G, Moore JH, Vancleave TT, States JC, Kittles RA, Kidd LC. No association between variant DNA repair genes and prostate cancer risk among men of African descent. Prostate. 2010; 70: 113-9. doi: 10.1002/pros.21048
60. Dhillon VS, Yeoh E, Fenech M. DNA repair gene polymorphisms and prostate cancer risk in South Australia-results of a pilot study. Urol Oncol. 2011; 29: 641-6. doi: 10.1016/j.urolonc.2009.08.013
61. Yuan T, Deng S, Chen M, Chen W, Lu W, Huang H, Xia J. Association of DNA repair gene XRCC1 and XPD polymorphisms with genetic susceptibility to gastric cancer in a Chinese population. Cancer Epidemiol. 2011; 35: 170-4. doi: 10.1016/j.canep.2010.08.008
62. Chen Z, Zhang C, Xu C, Li K, Hou R, Li D, Cheng X. Effects of selected genetic polymorphisms in xeroderma pigmentosum complementary group D on gastric cancer. Mol Biol Rep. 2011; 38: 1507-13. doi: 10.1007/s11033-010-0258-0
63. Ruzzo A, Canestrari E, Maltese P, Pizzagalli F, Graziano F, Santini D, Catalano V, Ficarelli R, Mari D, Bisonni R, Giordani P, Giustini L, Lippe P, et al. Polymorphisms in genes involved in DNA repair and metabolism of xenobiotics in individual susceptibility to sporadic diffuse gastric cancer. Clin Chem Lab Med. 2007; 45: 822-8. doi: 10.1515/cclm.2007.143
64. Yuan T, Deng S, Chen M, Chen W, Lu W, Huang H, Xia J. Association of DNA repair gene polymorphisms with genetic susceptibility to gastric cancer. J Mol Diagn Ther. 2010; 2: 371-4
65. Zhang CZ, Chen ZP, Xu CQ, Ning T, Li DP, Hou RP. [Correlation of XPD gene with susceptibility to gastric cancer]. [Article in Chinese]. Ai Zheng. 2009; 28: 1163-7
66. Yi Lou QBS, Xiang-Min He. Association of single nucleotide polymorphism in DNA repair gene XPD with gastric cancer in Han population from northeast region of China. Shijie Huaren Xiaohua Zazhi. 2006; 14: 3143-6
67. Zhou R, Li Y, Wand N, Dong X, Zhang X, Guo W. Correlation between single nucleotide polymorphism of DNA repair gene XPD and the risks of esophageal squamous cell carcinoma and gastric cardiacadeno carcinoma. Epidemiological Research. 2007; 27: 118-33. doi: 10.1155/2016/7495135
68. Lou Y, Song Q, He X. Association of single nucleotide polymorphism in DNA repair gene XPD with gastric cancer in Han population from northeast region of China. World Chinese Journal of Digestology. 2006; 14: 3143-6
69. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis. 2005; 26: 1263-71. doi: 10.1093/carcin/bgi063
70. Matullo G, Guarrera S, Sacerdote C, Polidoro S, Davico L, Gamberini S, Karagas M, Casetta G, Rolle L, Piazza A, Vineis P. Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case-control study. Cancer Epidemiol Biomarkers Prev. 2005; 14: 2569-78. doi: 10.1158/1055-9965.epi-05-0189
71. Matullo G, Dunning AM, Guarrera S, Baynes C, Polidoro S, Garte S, Autrup H, Malaveille C, Peluso M, Airoldi L, Veglia F, Gormally E, Hoek G, et al. DNA repair polymorphisms and cancer risk in non-smokers in a cohort study. Carcinogenesis. 2006; 27: 997-1007. doi: 10.1093/carcin/bgi280
72. Schabath MB, Delclos GL, Grossman HB, Wang Y, Lerner SP, Chamberlain RM, Spitz MR, Wu X. Polymorphisms in XPD exons 10 and 23 and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2005; 14: 878-84. doi: 10.1158/1055-9965.epi-04-0235
73. Andrew AS, Nelson HH, Kelsey KT, Moore JH, Meng AC, Casella DP, Tosteson TD, Schned AR, Karagas MR. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis. 2006; 27: 1030-7. doi: 10.1093/carcin/bgi284
74. Garcia-Closas M, Malats N, Real FX, Welch R, Kogevinas M, Chatterjee N, Pfeiffer R, Silverman D, Dosemeci M, Tardon A, Serra C, Carrato A, Garcia-Closas R, et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev. 2006; 15: 536-42. doi: 10.1158/1055-9965.epi-05-0749
75. Wu X, Gu J, Grossman HB, Amos CI, Etzel C, Huang M, Zhang Q, Millikan RE, Lerner S, Dinney CP, Spitz MR. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006; 78: 464-79. doi: 10.1086/500848
76. Fontana L, Bosviel R, Delort L, Guy L, Chalabi N, Kwiatkowski F, Satih S, Rabiau N, Boiteux JP, Chamoux A, Bignon YJ, Bernard-Gallon DJ. DNA repair gene ERCC2, XPC, XRCC1, XRCC3 polymorphisms and associations with bladder cancer risk in a French cohort. Anticancer Res. 2008; 28: 1853-6
77. Chang CH, Wang RF, Tsai RY, Wu HC, Wang CH, Tsai CW, Chang CL, Tsou YA, Liu CS, Bau DT. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan. Anticancer Res. 2009; 29: 3903-7
78. Gangwar R, Ahirwar D, Mandhani A, Mittal RD. Influence of XPD and APE1 DNA repair gene polymorphism on bladder cancer susceptibility in north India. Urology. 2009; 73: 675-80. doi: 10.1016/j.urology.2008.09.043
79. Mittal RD, Mandal RK. Genetic variation in nucleotide excision repair pathway genes influence prostate and bladder cancer susceptibility in North Indian population. Indian J Hum Genet. 2012; 18: 47-55. doi: 10.4103/0971-6866.96648
80. Ramaniuk VP, Nikitchenko NV, Savina NV, Kuzhir TD, Rolevich AI, Krasny SA, Sushinsky VE, Goncharova RI. Polymorphism of DNA repair genes OGG1, XRCC1, XPD and ERCC6 in bladder cancer in Belarus. Biomarkers. 2014; 19: 509-16. doi: 10.3109/1354750x.2014.943291
81. Zhou M, Wan HY, Gao BL, Ding YJ, Jun RX. Genetic polymorphisms of XPD and CDA and lung cancer risk. Oncol Lett. 2012; 4: 247-51. doi: 10.3892/ol.2012.716
82. Sakoda LC, Loomis MM, Doherty JA, Julianto L, Barnett MJ, Neuhouser ML, Thornquist MD, Weiss NS, Goodman GE, Chen C. Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers. Int J Mol Epidemiol Genet. 2012; 3: 1-17
83. Qian B, Zhang H, Zhang L, Zhou X, Yu H, Chen K. Association of genetic polymorphisms in DNA repair pathway genes with non-small cell lung cancer risk. Lung Cancer. 2011; 73: 138-46. doi: 10.1016/j.lungcan.2010.11.018
84. Yin Z, Su M, Li X, Li M, Ma R, He Q, Zhou B. ERCC2, ERCC1 polymorphisms and haplotypes, cooking oil fume and lung adenocarcinoma risk in Chinese non-smoking females. J Exp Clin Cancer Res. 2009; 28: 153. doi: 10.1186/1756-9966-28-153
85. Raaschou-Nielsen O, Sorensen M, Overvad K, Tjonneland A, Vogel U. Polymorphisms in nucleotide excision repair genes, smoking and intake of fruit and vegetables in relation to lung cancer. Lung Cancer. 2008; 59: 171-9. doi: 10.1016/j.lungcan.2007.08.018
86. Chang JS, Wrensch MR, Hansen HM, Sison JD, Aldrich MC, Quesenberry CP Jr, Seldin MF, Kelsey KT, Kittles RA, Silva G, Wiencke JK. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int J Cancer. 2008; 123: 2095-104. doi: 10.1002/ijc.23801
87. Yin J, Vogel U, Ma Y, Qi R, Sun Z, Wang H. A haplotype encompassing the variant allele of DNA repair gene polymorphism ERCC2/XPD Lys751Gln but not the variant allele of Asp312Asn is associated with risk of lung cancer in a northeastern Chinese population. Cancer Genet Cytogenet. 2007; 175: 47-51. doi: 10.1016/j.cancergencyto.2007.01.010
88. Lopez-Cima MF, Gonzalez-Arriaga P, Garcia-Castro L, Pascual T, Marron MG, Puente XS, Tardon A. Polymorphisms in XPC, XPD, XRCC1, and XRCC3 DNA repair genes and lung cancer risk in a population of northern Spain. BMC Cancer. 2007; 7: 162. doi: 10.1186/1471-2407-7-162
89. Zienolddiny S, Campa D, Lind H, Ryberg D, Skaug V, Stangeland L, Phillips DH, Canzian F, Haugen A. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis. 2006; 27: 560-7. doi: 10.1093/carcin/bgi232
90. Hu Z, Xu L, Shao M, Yuan J, Wang Y, Wang F, Yuan W, Qian J, Ma H, Wang Y, Liu H, Chen W, Yang L, et al. Polymorphisms in the two helicases ERCC2/XPD and ERCC3/XPB of the transcription factor IIH complex and risk of lung cancer: a case-control analysis in a Chinese population. Cancer Epidemiol Biomarkers Prev. 2006; 15: 1336-40. doi: 10.1158/1055-9965.epi-06-0194
91. Shen M, Berndt SI, Rothman N, Demarini DM, Mumford JL, He X, Bonner MR, Tian L, Yeager M, Welch R, Chanock S, Zheng T, Caporaso N, et al. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int J Cancer. 2005; 116: 768-73. doi: 10.1002/ijc.21117
92. Huang WY, Berndt SI, Kang D, Chatterjee N, Chanock SJ, Yeager M, Welch R, Bresalier RS, Weissfeld JL, Hayes RB. Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk. Cancer Epidemiol Biomarkers Prev. 2006; 15: 306-11. doi: 10.1158/1055-9965.epi-05-0751
93. De Ruyck K, Szaumkessel M, De Rudder I, Dehoorne A, Vral A, Claes K, Velghe A, Van Meerbeeck J, Thierens H. Polymorphisms in base-excision repair and nucleotide-excision repair genes in relation to lung cancer risk. Mutat Res. 2007; 631: 101-10. doi: 10.1016/j.mrgentox.2007.03.010
94. Crew KD, Gammon MD, Terry MB, Zhang FF, Zablotska LB, Agrawal M, Shen J, Long CM, Eng SM, Sagiv SK, Teitelbaum SL, Neugut AI, Santella RM. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2007; 16: 2033-41. doi: 10.1158/1055-9965.epi-07-0096
95. Kuschel B, Chenevix-Trench G, Spurdle AB, Chen X, Hopper JL, Giles GG, McCredie M, Chang-Claude J, Gregory CS, Day NE, Easton DF, Ponder BA, Dunning AM, et al. Common polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not associated with breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005; 14: 1828-31. doi: 10.1158/1055-9965.epi-04-0807
96. Jorgensen TJ, Visvanathan K, Ruczinski I, Thuita L, Hoffman S, Helzlsouer KJ. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland. Breast Cancer Res Treat. 2007; 101: 65-71. doi: 10.1007/s10549-006-9263-3
97. Lee SA, Lee KM, Park WY, Kim B, Nam J, Yoo KY, Noh DY, Ahn SH, Hirvonen A, Kang D. Obesity and genetic polymorphism of ERCC2 and ERCC4 as modifiers of risk of breast cancer. Exp Mol Med. 2005; 37: 86-90. doi: 10.1038/emm.2005.12
98. Bernard-Gallon D, Bosviel R, Delort L, Fontana L, Chamoux A, Rabiau N, Kwiatkowski F, Chalabi N, Satih S, Bignon YJ. DNA repair gene ERCC2 polymorphisms and associations with breast and ovarian cancer risk. Mol Cancer. 2008; 7: 36. doi: 10.1186/1476-4598-7-36
99. Jakubowska A, Gronwald J, Menkiszak J, Gorski B, Huzarski T, Byrski T, Toloczko-Grabarek A, Gilbert M, Edler L, Zapatka M, Eils R, Lubinski J, Scott RJ, et al. BRCA1-associated breast and ovarian cancer risks in Poland: no association with commonly studied polymorphisms. Breast Cancer Res Treat. 2010; 119: 201-11. doi: 10.1007/s10549-009-0390-5
100. Mechanic LE, Millikan RC, Player J, de Cotret AR, Winkel S, Worley K, Heard K, Heard K, Tse CK, Keku T. Polymorphisms in nucleotide excision repair genes, smoking and breast cancer in African Americans and whites: a population-based case-control study. Carcinogenesis. 2006; 27: 1377-85. doi: 10.1093/carcin/bgi330
101. Shen J, Desai M, Agrawal M, Kennedy DO, Senie RT, Santella RM, Terry MB. Polymorphisms in nucleotide excision repair genes and DNA repair capacity phenotype in sisters discordant for breast cancer. Cancer Epidemiol Biomarkers Prev. 2006; 15: 1614-9. doi: 10.1158/1055-9965.epi-06-0218
102. Smith TR, Levine EA, Freimanis RI, Akman SA, Allen GO, Hoang KN, Liu-Mares W, Hu JJ. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis. 2008; 29: 2132-8. doi: 10.1093/carcin/bgn193
103. Zhang L, Zhang Z, Yan W. Single nucleotide polymorphisms for DNA repair genes in breast cancer patients. Clin Chim Acta. 2005; 359: 150-5. doi: 10.1016/j.cccn.2005.03.047
104. Hussien YM, Gharib AF, Awad HA, Karam RA, Elsawy WH. Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients. Mol Biol Rep. 2012; 39: 1895-901. doi: 10.1007/s11033-011-0935-7
105. Jelonek K, Gdowicz-Klosok A, Pietrowska M, Borkowska M, Korfanty J, Rzeszowska-Wolny J, Widlak P. Association between single-nucleotide polymorphisms of selected genes involved in the response to DNA damage and risk of colon, head and neck, and breast cancers in a Polish population. J Appl Genet. 2010; 51: 343-52. doi: 10.1007/bf03208865
106. Wang HC, Liu CS, Wang CH, Tsai RY, Tsai CW, Wang RF, Chang CH, Chen YS, Chiu CF, Bau DT, Huang CY. Significant association of XPD Asp312Asn polymorphism with breast cancer in Taiwanese patients. Chin J Physiol. 2010; 53: 130-5
107. Lin QJ, Yang F, Jin C, Fu DL. Current status and progress of pancreatic cancer in China. World J Gastroenterol. 2015; 21: 7988-8003. doi: 10.3748/wjg.v21.i26.7988
108. Zhang M, Wang Y, Fang T, Cai Y, Xu Y, Yan C, Zhang L, Liang C. Common polymorphisms in CD44 gene and susceptibility to cancer: A systematic review and metaanalysis of 45 studies. Oncotarget. 2016; 7:76021-76035. doi: 10.18632/oncotarget.12580
109. Zhang CD, Li HT, Liu K, Lin ZD, Peng QL, Qin X, He M, Wu H, Mo ZN, Yang XL. Impact of caspase-8 (CASP8)-652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups. Asian Pac J Cancer Prev. 2014; 15: 7713-8
110. Fu W, Zhuo ZJ, Chen YC, Zhu J, Zhao Z, Jia W, Hu JH, Fu K, Zhu SB, He J, Liu GC. NFKB1-94insertion/deletion ATTG polymorphism and cancer risk: Evidence from 50 case-control studies. Oncotarget. 2016; 8:9806-9822. doi: 10.18632/oncotarget.14190
111. Xie SZ, Liu ZZ, Yu JH, Liu L, Wang W, Xie DL, Qin JB. Association between the MTHFR C677T polymorphism and risk of cancer: evidence from 446 case-control studies. Tumour Biol. 2015; 36: 8953-72. doi: 10.1007/s13277-015-3648-z
112. Tang J, Li X, Jiang X, Xu W, Xu Z, Wang W, Liu B, Lv Q, Zhang W. The association between rs9642880 gene polymorphism and bladder cancer risk: a meta-analysis. Int J Clin Exp Med. 2015; 8: 20236-44
113. Zhu HL, Bao JM, Lin PX, Li WX, Zou ZN, Huang YE, Chen Q, Shen H. XPD Lys751Gln and Asp312Asn polymorphisms and susceptibility to skin cancer: a metaanalysis of 17 case-control studies. Asian Pac J Cancer Prev. 2014; 15: 6619-25
114. Chen S, Zhu JH, Wang F, Huang SY, Xue WQ, Cui Z, He J, Jia WH. Association of the Asp312Asn and Lys751Gln polymorphisms in the XPD gene with the risk of non-Hodgkin's lymphoma: evidence from a metaanalysis. Chin J Cancer. 2015; 34: 108-14. doi: 10.1186/s40880-015-0001-2
115. Ma Q, Qi C, Tie C, Guo Z. Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis. Gene. 2013; 530: 309-14. doi: 10.1016/j.gene.2013.08.053
116. Wu KG, He XF, Li YH, Xie WB, Huang X. Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case-control studies. Tumour Biol. 2014; 35: 11243-59. doi: 10.1007/s13277-014-2379-x
117. Padma G, Mamata M, Reddy KR, Padma T. Polymorphisms in two DNA repair genes (XPD and XRCC1)-association with age related cataracts. Mol Vis. 2011; 17: 127-33
118. Ji G, Gu A, Xia Y, Lu C, Liang J, Wang S, Ma J, Peng Y, Wang X. ERCC1 and ERCC2 polymorphisms and risk of idiopathic azoospermia in a Chinese population. Reprod Biomed Online. 2008; 17: 36-41
119. McCarty KM, Smith TJ, Zhou W, Gonzalez E, Quamruzzaman Q, Rahman M, Mahiuddin G, Ryan L, Su L, Christiani DC. Polymorphisms in XPD (Asp312Asn and Lys751Gln) genes, sunburn and arsenic-related skin lesions. Carcinogenesis. 2007; 28: 1697-702. doi: 10.1093/carcin/bgm099
120. Xiao F, Lan A, Lin Z, Song J, Zhang Y, Li J, Gu K, Lv B, Zhao D, Zeng S, Zhang R, Zhao W, Pan Z, et al. Impact of CAG repeat length in the androgen receptor gene on male infertility-a meta-analysis. Reprod Biomed Online. 2016; 33: 39-49. doi: 10.1016/j.rbmo.2016.03.012
121. Varvaki Rados D, Catani Pinto L, Reck Remonti L, Bauermann Leitao C, Gross JL. The Association between Sulfonylurea Use and All-Cause and Cardiovascular Mortality: A Meta-Analysis with Trial Sequential Analysis of Randomized Clinical Trials. PLoS Med. 2016; 13: e1001992. doi: 10.1371/journal.pmed.1001992
122. Wang G, Zhang L, Lou S, Chen Y, Cao Y, Wang R, Zhang L, Tang P. Effect of Dexmedetomidine in Preventing Postoperative Side Effects for Laparoscopic Surgery: A Meta-Analysis of Randomized Controlled Trials and Trial Sequential Analysis (PRISMA). Medicine (Baltimore). 2016; 95: e2927. doi: 10.1097/md.0000000000002927
123. Zhang Y, Li M, Xiao F, Teng R, Zhang C, Lan A, Gu K, Li J, Wang D, Li H, Jiang L, Zeng S, He M, et al. Impact of partial DAZ1/2 deletion and partial DAZ3/4 deletion on male infertility. Gene. 2015; 571: 9-16. doi: 10.1016/j.gene.2015.07.083
124. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. Bmj. 2003; 327: 557-60. doi: 10.1136/bmj.327.7414.557
125. Zhai Y, Dai Z, He H, Gao F, Yang L, Dong Y, Lu J. A PRISMA-compliant meta-analysis of MDM4 genetic variants and cancer susceptibility. Oncotarget. 2016; 7:73935-73944. doi: 10.18632/oncotarget.12558
126. Luo M, Yang Y, Luo D, Liu L, Zhang Y, Xiao F, Yang J, Zhang C, Fu S, Luo Z. Tumor necrosis factor-alpha promoter polymorphism 308 G/A is not significantly associated with esophageal cancer risk: a meta-analysis. Oncotarget. 2016; 7:79901-79913. doi: 10.18632/oncotarget.13093
127. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L. Comparison of two methods to detect publication bias in meta-analysis. Jama. 2006; 295: 676-80. doi: 10.1001/jama.295.6.676